Applied DNA Sciences Inc (APDN): Rasio kapitalisasi marang pendapatan
Geopolitical tensions are driving demand for DNA tagging, although sanctions may complicate equipment procurement. Analyzing the current price-to-sales ratio on GURU.Markets, we see that 2.20 represents the latest level. The proprietary LinearDNA platform provides Applied DNA Sciences (APDN) with a strong competitive moat. However, the transition to contract RNA synthesis and a liquidity shortage create significant operational risks for the company.
Rincian analitis perusahaan Applied DNA (APDN)
- rega saham lan target rega konsensus:
- data kapitalisasi bursa:
- rincian valuasi buku bisnis:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Applied DNA Sciences|APDN - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Applied DNA Corp|APDN - Gunggung utang perusahaan|Utang-utang marang aset resik Applied DNA|APDN - Utang jangka dawa perusahaan|Utang jangka cendhak Applied DNA Sciences|Rasio likuiditas darurat adnas.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
APDN - Bathi resik|Bathi mangsa ngarep Applied DNA Sciences|APDN - Pangali P/E|Rasio prakiraan rega marang bathi Applied DNA Sciences Inc|APDN - Rasio rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Applied DNA|APDN - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Applied DNA Sciences|APDN - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan adnas.com|APDN - Wutah bathi ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Applied DNA Sciences
- indikator pendapatan dodolan lan penghasilan bisnis:
Analisis umum perusahaan:APDN, adnas.com
For Applied DNA Sciences (APDN), the market valuation relative to the sales volumes of PCR tests and anti-counterfeiting systems reflects investor confidence in the scalability of its genetic technologies. This ratio correlates total market capitalization with annual revenue; therefore, analyzing the price-to-sales trend allows for the identification of an overbought asset and helps avoid entering a position at the peak of speculative optimism.
Perusahaan pesaing
Tempus AI - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan Qiagen QGEN|IONS: Rasio kapitalisasi marang pendapatan|Repligen Corp. - Multiplikator P/S|RNA - Multiplikator P/S|CRSP (CRISPR Therapeutics AG) - Kapitalisasi marang pendapatan|genedx.com - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Ultragenyx|Beam Therapeutics Inc (BEAM) - Koefisien rega marang pendapatan|Multiplikator P/S SRPT|Kapitalisasi marang pendapatan Twist Bioscience Corp TWST|Multiplikator P/S TXG (10x Genomics, Inc.)|Koefisien rega marang pendapatan intelliatx.com (NTLA)|Stoke Therapeutics, Inc. - Multiplikator P/S|Rega marang dodolan BioLife Solutions Inc|Wave Life Sciences Corp (WVE) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan MAZE|SION (Sionna Therapeutics Inc) - Multiplikator P/S|Kapitalisasi marang pendapatan primemedicine.com (PRME)|Multiplikator P/S TSHA|QURE - Rega marang dodolan|Rasio rega marang pendapatan MeiraGTx PLC MGTX|Koefisien rega marang pendapatan REGENXBIO Corp (RGNX)|Solid Biosciences Inc. - Multiplikator P/S|OCGN - Multiplikator P/S|PacBio (PACB) - Rasio rega marang pendapatan|Rasio rega marang dodolan BNTC (Benitec Biopharma Inc)|DSGN (Design Pharma) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan RCKT (Rocket Corp)|Rasio rega marang pendapatan 4D Molecular Therapeutics (FDMT)|lexeotx.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S KRRO (Korro Bio)|EDIT: Rasio kapitalisasi marang pendapatan|SLN - Rasio rega marang pendapatan|PRQR (ProQR Therapeutics N.V.) - Rasio kapitalisasi marang pendapatan|CDXS: Multiplikator P/S|sangamo.com (SGMO) - Multiplikator P/S|NAUT (Nautilus Biotechnology, Inc.) - Multiplikator P/S|Multiplikator P/S Metagenomi Inc.|Rasio rega marang pendapatan Precision BioSciences, Inc. (DTIL)|GBIO: Rasio rega marang dodolan|Rasio rega marang pendapatan Boundless Bio, Inc. BOLD|XCUR (Exicure Inc.) - Rasio rega marang dodolan|IMNN - Rasio rega marang pendapatan|PHIO: Rasio rega marang pendapatan|MBIO: Multiplikator P/S|RNAZ - Koefisien rega marang pendapatan|BNGO (Bionano Genomics Inc.) - Multiplikator P/S|Rega marang dodolan bluebirdbio.com BLUE|Multiplikator P/S IPA|Omega Therapeutics Inc - Rasio kapitalisasi marang pendapatan|Singular Genomics Systems Inc - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan RGLS|Syros Pharmaceuticals - Multiplikator P/S|TBIO (telesisbio.com) - Rasio kapitalisasi marang pendapatan|TRACON Pharmaceuticals, Inc. (TCON) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan UBX
